These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11566623)

  • 21. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
    Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
    Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kinetics of cytokine production and CD25 expression by porcine lymphocyte subpopulations following exposure to classical swine fever virus (CSFV).
    Suradhat S; Sada W; Buranapraditkun S; Damrongwatanapokin S
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):197-208. PubMed ID: 15963818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
    Marchetti G; Meroni L; Varchetta S; Terzieva V; Bandera A; Manganaro D; Molteni C; Trabattoni D; Fossati S; Clerici M; Galli M; Moroni M; Franzetti F; Gori A
    J Infect Dis; 2002 Sep; 186(5):606-16. PubMed ID: 12195347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.
    Pacheco Y; Solé V; Billaud E; Allavena C; Plet A; Ferré V; Garrigue-Antar L; Raffi F; Jacques Y; McIlroy D
    AIDS; 2011 Sep; 25(14):1701-10. PubMed ID: 21673554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.
    Weiss L; Donkova-Petrini V; Caccavelli L; Balbo M; Carbonneil C; Levy Y
    Blood; 2004 Nov; 104(10):3249-56. PubMed ID: 15271794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BAY 50-4798, a novel, high-affinity receptor-specific recombinant interleukin-2 analog, induces dose-dependent increases in CD25 expression and proliferation among unstimulated, human peripheral blood mononuclear cells in vitro.
    Matthews L; Chapman S; Ramchandani MS; Lane HC; Davey RT; Sereti I
    Clin Immunol; 2004 Dec; 113(3):248-55. PubMed ID: 15507389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease.
    Paganin C; Monos DS; Marshall JD; Frank I; Trinchieri G
    J Clin Invest; 1997 Feb; 99(4):663-8. PubMed ID: 9045868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients.
    Sereti I; Herpin B; Metcalf JA; Stevens R; Baseler MW; Hallahan CW; Kovacs JA; Davey RT; Lane HC
    AIDS; 2001 Sep; 15(14):1765-75. PubMed ID: 11579237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.
    Natarajan V; Lempicki RA; Sereti I; Badralmaa Y; Adelsberger JW; Metcalf JA; Prieto DA; Stevens R; Baseler MW; Kovacs JA; Lane HC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10712-7. PubMed ID: 12149467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation.
    Sereti I; Anthony KB; Martinez-Wilson H; Lempicki R; Adelsberger J; Metcalf JA; Hallahan CW; Follmann D; Davey RT; Kovacs JA; Lane HC
    Blood; 2004 Aug; 104(3):775-80. PubMed ID: 15090457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.
    Sereti I; Imamichi H; Natarajan V; Imamichi T; Ramchandani MS; Badralmaa Y; Berg SC; Metcalf JA; Hahn BK; Shen JM; Powers A; Davey RT; Kovacs JA; Shevach EM; Lane HC
    J Clin Invest; 2005 Jul; 115(7):1839-47. PubMed ID: 15937547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of interleukin-2 in HIV.
    Mitsuyasu RT
    AIDS; 2001 Feb; 15 Suppl 2():S22-7. PubMed ID: 11424973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects.
    Caggiari L; Zanussi S; Crepaldi C; Bortolin MT; Caffau C; D'Andrea M; De Paoli P
    Cytometry; 2001 Aug; 46(4):233-7. PubMed ID: 11514956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2.
    De Paoli P; Zanussi S; Caggiari L; Bortolin MT; D'Andrea M; Simonelli C; Tirelli U
    J Clin Immunol; 1999 Sep; 19(5):317-25. PubMed ID: 10535609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy.
    David D; Keller H; Naït-Ighil L; Treilhou MP; Joussemet M; Dupont B; Gachot B; Maral J; Thèze J
    AIDS; 2002 May; 16(8):1093-101. PubMed ID: 12004267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients.
    Read SW; Ciccone EJ; Mannon PJ; Yao MD; Chairez CL; Davey RT; Kovacs JA; Sereti I
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):340-3. PubMed ID: 21350367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.